Tekla Healthcare Investors (HQH) N-PX Annual report of proxy voting record

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549	OMB APPROVAL
	OMB Number:  3235-0582
	Expires:  March 31, 2018
	Estimated average burden
	hours per response........7.2

FORM N-PX

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number 811- 04889

Tekla Healthcare Investors

(Exact name of registrant as specified in charter)

100 Federal Street, 19th Floor, Boston, MA	02110
(Address of principal executive offices)	(Zip code)

Laura Woodward

Tekla Healthcare Investors

100 Federal Street, 19th Floor, Boston MA 02110

(Name and address of agent for service)

Registrant’s telephone number, including area code: 617-772-8500

Date of fiscal year end: September 30

Date of reporting period: 7/1/16-6/30/17

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss.239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4).  The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public.  A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number.  Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609.  The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

Item 1. Proxy Voting Record.

Vote Summary

ABBOTT LABORATORIES

Security	002824100	Meeting Type	Annual
Ticker Symbol	ABT	Meeting Date	28-Apr-2017
Record Date	01-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1R.J. ALPERN		For	For
	2R.S. AUSTIN		For	For
	3S.E. BLOUNT		For	For
	4E.M. LIDDY		For	For
	5N. MCKINSTRY		For	For
	6P.N. NOVAKOVIC		For	For
	7W.A. OSBORN		For	For
	8S.C. SCOTT III		For	For
	9D.J. STARKS		For	For
	10G.F. TILTON		For	For
	11M.D. WHITE		For	For
2.	RATIFICATION OF ERNST & YOUNG LLP AS AUDITORS.	Management	For	For
3.	SAY ON PAY - AN ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION.	Management	For	For
4.	SAY WHEN ON PAY - AN ADVISORY VOTE TO APPROVE THE FREQUENCY OF SHAREHOLDER VOTES ON EXECUTIVE COMPENSATION.	Management	1 Year	For
5.	APPROVAL OF THE ABBOTT LABORATORIES 2017 INCENTIVE STOCK PROGRAM	Management	For	For
6.	APPROVAL OF THE ABBOTT LABORATORIES 2017 EMPLOYEE STOCK PURCHASE PLAN FOR NON-U.S. EMPLOYEES.	Management	For	For
7.	SHAREHOLDER PROPOSAL - INDEPENDENT BOARD CHAIRMAN.	Shareholder	Against	For

AKORN, INC.

Security	009728106	Meeting Type	Special
Ticker Symbol	AKRX	Meeting Date	16-Dec-2016
Record Date	28-Oct-2016

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	PROPOSAL TO APPROVE THE AKORN, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN.	Management	For	For
2.	PROPOSAL TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE AKORN, INC. 2014 STOCK OPTION PLAN.	Management	For	For

AKORN, INC.

Security	009728106	Meeting Type	Annual
Ticker Symbol	AKRX	Meeting Date	27-Apr-2017
Record Date	13-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1JOHN KAPOOR, PHD		For	For
	2KENNETH ABRAMOWITZ		For	For
	3ADRIENNE GRAVES, PHD		For	For
	4RONALD JOHNSON		For	For
	5STEVEN MEYER		For	For
	6TERRY ALLISON RAPPUHN		For	For
	7BRIAN TAMBI		For	For
	8ALAN WEINSTEIN		For	For
2.	PROPOSAL TO RATIFY THE APPOINTMENT OF BDO USA, LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2017.	Management	For	For
3.	PROPOSAL TO APPROVE THE 2017 OMNIBUS INCENTIVE COMPENSATION PLAN.	Management	For	For
4.	PROPOSAL TO APPROVE, THROUGH A NON- BINDING ADVISORY VOTE, THE FREQUENCY OF FUTURE NON-BINDING ADVISORY VOTES ON THE COMPANY’S EXECUTIVE COMPENSATION PROGRAMS.	Management	1 Year	For
5.	PROPOSAL TO APPROVE, THROUGH A NON-BINDING ADVISORY VOTE, THE COMPANY’S EXECUTIVE COMPENSATION PROGRAM AS DESCRIBED IN THE COMPANY’S 2017 PROXY STATEMENT.	Management	For	For

AKORN, INC.

Security	009728106	Meeting Type	Special
Ticker Symbol	AKRX	Meeting Date	19-Jul-2017
Record Date	09-Jun-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	TO APPROVE THE AGREEMENT AND PLAN OF MERGER, DATED AS OF APRIL 24, 2017, BY AND AMONG FRESENIUS KABI AG, QUERCUS ACQUISITION, INC., AKORN, INC. AND, SOLELY FOR PURPOSES OF ARTICLE VIII THEREIN, FRESENIUS SE & CO. KGAA.	Management	For	For
2.	TO APPROVE, BY NON-BINDING, ADVISORY VOTE, THE COMPENSATION THAT MAY BE PAID OR MAY BECOME PAYABLE TO AKORN, INC.’S NAMED EXECUTIVE OFFICERS IN CONNECTION WITH, OR FOLLOWING, THE CONSUMMATION OF THE MERGER CONTEMPLATED BY THE AGREEMENT AND PLAN OF MERGER.	Management	For	For
3.	TO APPROVE THE ADJOURNMENT OF THE SPECIAL MEETING TO A LATER DATE OR TIME, IF NECESSARY OR APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES IN THE EVENT THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE SPECIAL MEETING OR ANY ADJOURNMENT OR POSTPONEMENT THEREOF TO ADOPT THE AGREEMENT AND PLAN OF MERGER.	Management	For	For

ALEXION PHARMACEUTICALS, INC.

Security	015351109	Meeting Type	Annual
Ticker Symbol	ALXN	Meeting Date	10-May-2017
Record Date	14-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: FELIX J. BAKER	Management	For	For
1B.	ELECTION OF DIRECTOR: DAVID R. BRENNAN	Management	For	For
1C.	ELECTION OF DIRECTOR: M. MICHELE BURNS	Management	For	For
1D.	ELECTION OF DIRECTOR: CHRISTOPHER J. COUGHLIN	Management	For	For
1E.	ELECTION OF DIRECTOR: LUDWIG N. HANTSON	Management	For	For
1F.	ELECTION OF DIRECTOR: JOHN T. MOLLEN	Management	For	For
1G.	ELECTION OF DIRECTOR: R. DOUGLAS NORBY	Management	For	For
1H.	ELECTION OF DIRECTOR: ALVIN S. PARVEN	Management	For	For
1I.	ELECTION OF DIRECTOR: ANDREAS RUMMELT	Management	For	For
1J.	ELECTION OF DIRECTOR: ANN M. VENEMAN	Management	For	For
2.	TO APPROVE ALEXION’S 2017 INCENTIVE PLAN.	Management	For	For
3.	RATIFICATION OF APPOINTMENT BY THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS ALEXION’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.	Management	For	For
4.	APPROVAL OF A NON-BINDING ADVISORY VOTE OF THE 2016 COMPENSATION PAID TO ALEXION’S NAMED EXECUTIVE OFFICERS.	Management	For	For
5.	TO RECOMMEND, BY NON-BINDING VOTE, THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION.	Management	1 Year	For
6.	TO REQUEST THE BOARD IMPLEMENT CONFIDENTIAL SHAREHOLDER VOTING ON EXECUTIVE PAY MATTERS.	Shareholder	Against	For

ALLERGAN PLC

Security	G0177J108	Meeting Type	Annual
Ticker Symbol	AGN	Meeting Date	04-May-2017
Record Date	08-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: NESLI BASGOZ, M.D.	Management	For	For
1B.	ELECTION OF DIRECTOR: PAUL M. BISARO	Management	For	For
1C.	ELECTION OF DIRECTOR: JAMES H. BLOEM	Management	For	For
1D.	ELECTION OF DIRECTOR: CHRISTOPHER W. BODINE	Management	For	For
1E.	ELECTION OF DIRECTOR: ADRIANE M. BROWN	Management	For	For
1F.	ELECTION OF DIRECTOR: CHRISTOPHER J. COUGHLIN	Management	For	For
1G.	ELECTION OF DIRECTOR: CATHERINE M. KLEMA	Management	For	For
1H.	ELECTION OF DIRECTOR: PETER J. MCDONNELL, M.D.	Management	For	For
1I.	ELECTION OF DIRECTOR: PATRICK J. O’SULLIVAN	Management	For	For
1J.	ELECTION OF DIRECTOR: BRENTON L. SAUNDERS	Management	For	For
1K.	ELECTION OF DIRECTOR: RONALD R. TAYLOR	Management	For	For
1L.	ELECTION OF DIRECTOR: FRED G. WEISS	Management	For	For
2.	TO APPROVE, IN A NON-BINDING VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.	Management	For	For
3.	TO RECOMMEND, IN A NON-BINDING VOTE, WHETHER A SHAREHOLDER VOTE TO APPROVE THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS SHOULD OCCUR EVERY ONE, TWO OR THREE YEARS.	Management	1 Year	For
4.	TO RATIFY, IN A NON-BINDING VOTE, THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT AUDITOR FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017 AND TO AUTHORIZE, IN A BINDING VOTE, THE BOARD OF DIRECTORS, ACTING THROUGH ITS AUDIT AND COMPLIANCE COMMITTEE, TO DETERMINE PRICEWATERHOUSECOOPERS LLP’S REMUNERATION.	Management	For	For
5.	TO APPROVE THE MATERIAL TERMS OF THE PERFORMANCE GOALS FOR THE PURPOSES OF SECTION 162(M) UNDER THE ALLERGAN PLC 2017 ANNUAL INCENTIVE COMPENSATION PLAN.	Management	For	For
6.	TO CONSIDER A SHAREHOLDER PROPOSAL REGARDING AN INDEPENDENT BOARD CHAIRMAN, IF PROPERLY PRESENTED AT THE MEETING.	Shareholder	Against	For

ALLIQUA BIOMEDICAL, INC.

Security	019621200	Meeting Type	Annual
Ticker Symbol	ALQA	Meeting Date	23-Jun-2017
Record Date	28-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1DAVID JOHNSON		For	For
	2WINSTON KUNG		For	For
	3JOSEPH LEONE		For	For
	4GARY RESTANI		For	For
	5JEFFREY SKLAR		For	For
	6MARK WAGNER		For	For
	7JEROME ZELDIS, MD, PHD.		For	For
2.	APPROVAL TO AUTHORIZE THE BOARD OF DIRECTORS OF THE COMPANY TO AMEND THE COMPANY’S CERTIFICATE OF INCORPORATION IN ITS DISCRETION BUT PRIOR TO THE ANNUAL MEETING OF THE COMPANY’S STOCKHOLDERS IN 2018, TO EFFECT A REVERSE STOCK SPLIT OF THE COMPANY’S COMMON STOCK, AT A RATIO IN THE RANGE OF 1-FOR-3 TO 1-FOR-13.	Management	For	For
3.	APPROVAL OF AN AMENDMENT TO THE COMPANY’S 2014 LONG-TERM INCENTIVE PLAN, TO INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE UNDER THE 2014 PLAN BY AN ADDITIONAL 4,000,000 SHARES, TO A TOTAL OF 9,500,000 SHARES.	Management	For	For
4.	TO APPROVE THE ISSUANCE OF MORE THAN 19.99% OF THE COMPANY’S OUTSTANDING COMMON STOCK AT A PRICE PER SHARE LESS THAN BOOK OR MARKET VALUE TO INVESTORS WHO PARTICIPATED IN A PRIVATE PLACEMENT WHICH CLOSED ON FEBRUARY 27, 2017 PURSUANT TO THE MFN ADJUSTMENT.	Management	For	For
5.	TO APPROVE THE ISSUANCE OF SHARES OF THE COMPANY’S COMMON STOCK TO JEROME ZELDIS, M.D., PH.D., THE CHAIRMAN OF THE COMPANY’S BOARD OF DIRECTORS, PURSUANT TO THE MFN ADJUSTMENT AT A PER SHARE PURCHASE PRICE LESS THAN THE CLOSING BID PRICE OF THE COMMON STOCK ON FEBRUARY 27, 2017.	Management	For	For
6.	TO APPROVE THE ISSUANCE OF SHARES OF THE COMPANY’S COMMON STOCK ...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL).	Management	For	For
7.	RATIFICATION OF THE APPOINTMENT OF MARCUM LLP AS OUR ...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL).	Management	For	For
8.	AN ADVISORY VOTE ON EXECUTIVE COMPENSATION AS DISCLOSED IN THESE MATERIALS.	Management	For	For

ALNYLAM PHARMACEUTICALS, INC.

Security	02043Q107	Meeting Type	Annual
Ticker Symbol	ALNY	Meeting Date	02-May-2017
Record Date	10-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: MICHAEL W. BONNEY	Management	For	For
1B.	ELECTION OF DIRECTOR: JOHN M. MARAGANORE, PH.D.	Management	For	For
1C.	ELECTION OF DIRECTOR: PAUL R. SCHIMMEL, PH.D.	Management	For	For
1D.	ELECTION OF DIRECTOR: PHILLIP A. SHARP, PH.D.	Management	For	For
2.	TO APPROVE THE SECOND AMENDED AND RESTATED 2009 STOCK INCENTIVE PLAN.	Management	For	For
3.	TO APPROVE THE AMENDED AND RESTATED 2004 EMPLOYEE STOCK PURCHASE PLAN.	Management	For	For
4.	TO APPROVE, IN A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF ALNYLAM’S NAMED EXECUTIVE OFFICERS.	Management	For	For
5.	TO RECOMMEND, IN A NON-BINDING ADVISORY VOTE, THE FREQUENCY OF ADVISORY STOCKHOLDER VOTES ON EXECUTIVE COMPENSATION.	Management	1 Year	For
6.	TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AS ALNYLAM’S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For

AMERISOURCEBERGEN CORPORATION

Security	03073E105	Meeting Type	Annual
Ticker Symbol	ABC	Meeting Date	02-Mar-2017
Record Date	03-Jan-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: ORNELLA BARRA	Management	For	For
1B.	ELECTION OF DIRECTOR: STEVEN H. COLLIS	Management	For	For
1C.	ELECTION OF DIRECTOR: DOUGLAS R. CONANT	Management	For	For
1D.	ELECTION OF DIRECTOR: D. MARK DURCAN	Management	For	For
1E.	ELECTION OF DIRECTOR: RICHARD W. GOCHNAUER	Management	For	For
1F.	ELECTION OF DIRECTOR: LON R. GREENBERG	Management	For	For
1G.	ELECTION OF DIRECTOR: JANE E. HENNEY, M.D.	Management	For	For
1H.	ELECTION OF DIRECTOR: KATHLEEN W. HYLE	Management	For	For
1I.	ELECTION OF DIRECTOR: MICHAEL J. LONG	Management	For	For
1J.	ELECTION OF DIRECTOR: HENRY W. MCGEE	Management	For	For
2.	RATIFICATION OF APPOINTMENT OF OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR 2017.	Management	For	For
3.	ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.	Management	For	For
4.	ADVISORY VOTE ON THE FREQUENCY OF A STOCKHOLDER VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.	Management	1 Year	For
5.	APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION SO THAT DIRECTORS MAY BE REMOVED WITH OR WITHOUT CAUSE.	Management	For	For

AMGEN INC.

Security	031162100	Meeting Type	Annual
Ticker Symbol	AMGN	Meeting Date	19-May-2017
Record Date	20-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: DR. DAVID BALTIMORE	Management	For	For
1B.	ELECTION OF DIRECTOR: MR. ROBERT A. BRADWAY	Management	For	For
1C.	ELECTION OF DIRECTOR: MR. FRANCOIS DE CARBONNEL	Management	For	For
1D.	ELECTION OF DIRECTOR: MR. ROBERT A. ECKERT	Management	For	For
1E.	ELECTION OF DIRECTOR: MR. GREG C. GARLAND	Management	For	For
1F.	ELECTION OF DIRECTOR: MR. FRED HASSAN	Management	For	For
1G.	ELECTION OF DIRECTOR: DR. REBECCA M. HENDERSON	Management	For	For
1H.	ELECTION OF DIRECTOR: MR. FRANK C. HERRINGER	Management	For	For
1I.	ELECTION OF DIRECTOR: MR. CHARLES M. HOLLEY, JR.	Management	For	For
1J.	ELECTION OF DIRECTOR: DR. TYLER JACKS	Management	For	For
1K.	ELECTION OF DIRECTOR: MS. ELLEN J. KULLMAN	Management	For	For
1L.	ELECTION OF DIRECTOR: DR. RONALD D. SUGAR	Management	For	For
1M.	ELECTION OF DIRECTOR: DR. R. SANDERS WILLIAMS	Management	For	For
2.	TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For
3.	ADVISORY VOTE TO APPROVE OUR EXECUTIVE COMPENSATION.	Management	For	For
4.	ADVISORY VOTE ON THE FREQUENCY OF FUTURE STOCKHOLDER VOTES TO APPROVE EXECUTIVE COMPENSATION.	Management	1 Year	For
5.	STOCKHOLDER PROPOSAL TO ADOPT MAJORITY VOTES CAST STANDARD FOR MATTERS PRESENTED BY STOCKHOLDERS.	Shareholder	Against	For

AURIS MEDICAL HOLDING AG

Security	H03579101	Meeting Type	Annual
Ticker Symbol	EARS	Meeting Date	13-Apr-2017
Record Date	10-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	APPROVAL OF THE ANNUAL REPORT, THE FINANCIAL STATEMENTS AND THE GROUP CONSOLIDATED FINANCIAL STATEMENTS FOR THE 2016 FINANCIAL YEAR	Management	For	For
2.	DISCHARGE OF LIABILITY FOR THE MEMBERS OF THE BOARD OF DIRECTORS AND THE PERSONS ENTRUSTED WITH THE CORPORATION’S MANAGEMENT	Management	For	For
3.	APPROPRIATION OF FINANCIAL RESULTS	Management	For	For
4.1	INCREASE OF THE AUTHORIZED SHARE CAPITAL	Management	For	For
4.2	INCREASE OF THE CONDITIONAL SHARE CAPITAL FOR FINANCING PURPOSES	Management	For	For
4.3	INCREASE OF THE CONDITIONAL SHARE CAPITAL FOR EQUITY INCENTIVE PLANS	Management	Against	Against
5.1	APPROVAL OF THE COMPENSATION OF THE BOARD OF DIRECTORS	Management	For	For
5.2	APPROVAL OF THE COMPENSATION OF THE MEMBERS OF THE EXECUTIVE MANAGEMENT COMMITTEE FOR THE 2018 FINANCIAL YEAR	Management	For	For
6.1	RE-ELECTION OF THOMAS MEYER AS MEMBER AND AS CHAIRMAN OF THE BOARD OF DIRECTORS	Management	For	For
6.2	RE-ELECTION OF ARMANDO ANIDO AS MEMBER OF THE BOARD OF DIRECTORS	Management	For	For
6.3	RE-ELECTION OF OLIVER KUBLI AS MEMBER OF THE BOARD OF DIRECTORS	Management	For	For
6.4	RE-ELECTION OF BERNDT A. MODIG AS MEMBER OF THE BOARD OF DIRECTORS	Management	For	For
6.5	RE-ELECTION OF ANTOINE PAPIERNIK-BERKHAUER AS MEMBER OF THE BOARD OF DIRECTORS	Management	For	For
6.6	RE-ELECTION OF CALVIN W. ROBERTS AS MEMBER OF THE BOARD OF DIRECTORS	Management	For	For
6.7	ELECTION OF MATS PETER BLOM AS MEMBER OF THE BOARD OF DIRECTORS	Management	For	For
7.1	RE-ELECTION OF ARMANDO ANIDO AS MEMBER OF THE COMPENSATION COMMITTEE	Management	For	For
7.2	RE-ELECTION OF CALVIN W. ROBERTS AS MEMBER OF THE COMPENSATION COMMITTEE	Management	For	For
8.	RE-ELECTION OF DELOITTE AG AS AUDITORS	Management	For	For
9.	RE-ELECTION OF THE INDEPENDENT PROXY	Management	For	For
10.	GENERAL INSTRUCTION ON NEW PROPOSALS OF THE BOARD OF DIRECTORS	Management	For	For

BECTON, DICKINSON AND COMPANY

Security	075887109	Meeting Type	Annual
Ticker Symbol	BDX	Meeting Date	24-Jan-2017
Record Date	02-Dec-2016

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: BASIL L. ANDERSON	Management	For	For
1B.	ELECTION OF DIRECTOR: CATHERINE M. BURZIK	Management	For	For
1C.	ELECTION OF DIRECTOR: R. ANDREW ECKERT	Management	For	For
1D.	ELECTION OF DIRECTOR: VINCENT A. FORLENZA	Management	For	For
1E.	ELECTION OF DIRECTOR: CLAIRE M. FRASER	Management	For	For
1F.	ELECTION OF DIRECTOR: CHRISTOPHER JONES	Management	For	For
1G.	ELECTION OF DIRECTOR: MARSHALL O. LARSEN	Management	For	For
1H.	ELECTION OF DIRECTOR: GARY A. MECKLENBURG	Management	For	For
1I.	ELECTION OF DIRECTOR: JAMES F. ORR	Management	For	For
1J.	ELECTION OF DIRECTOR: WILLARD J. OVERLOCK, JR.	Management	For	For
1K.	ELECTION OF DIRECTOR: CLAIRE POMEROY	Management	For	For
1L.	ELECTION OF DIRECTOR: REBECCA W. RIMEL	Management	For	For
1M.	ELECTION OF DIRECTOR: BERTRAM L. SCOTT	Management	For	For
2.	RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.	Management	For	For
3.	ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.	Management	For	For
4.	ADVISORY VOTE TO APPROVE THE FREQUENCY OF NAMED EXECUTIVE OFFICER COMPENSATION ADVISORY VOTES.	Management	Abstain
5.	SHAREHOLDER PROPOSAL REGARDING AN INDEPENDENT BOARD CHAIR.	Shareholder	Against	For

BIOCLIN THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	05-Oct-2016
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DETERMINATION REGARDING SECOND TRANCHE MILESTONE CLOSING OF PREFERRED STOCK FINANCING	Management	For	For
2.	NOTICE OF INTERESTED PARTY TRANSACTIONS	Management	For	For
3.	GENERAL AUTHORIZING RESOLUTION	Management	For	For

BIOCLIN THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	02-Mar-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	ELECTION OF DIRECTORS	Management	For	For
2.	GENERAL AUTHORIZING RESOLUTION	Management	For	For

BIOCLIN THERAPEUTICS, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	02-Mar-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	AMENDMENT AND RESTATEMENT OF RESTATED CERTIFICATE OF INCORPORATION	Management	For	For
2.	SERIES B PREFERRED STOCK FINANCING	Management	For	For
3.	WAIVER OF PREEMPTIVE RIGHTS	Management	For	For
4.	NOTICE OF INTERESTED PARTY TRANSACTIONS	Management	For	For
5.	APPROVAL OF INDEMNIFCATION AGREEMENTS	Management	For	For
6.	AMENDMENT OF 2013 STOCK AND OPTION GRANT PLAN	Management	For	For
7.	GENERAL AUTHORIZING RESOLUTION	Management	For	For

BIOGEN INC.

Security	09062X103	Meeting Type	Annual
Ticker Symbol	BIIB	Meeting Date	07-Jun-2017
Record Date	10-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: ALEXANDER J. DENNER	Management	For	For
1B.	ELECTION OF DIRECTOR: CAROLINE D. DORSA	Management	For	For
1C.	ELECTION OF DIRECTOR: NANCY L. LEAMING	Management	For	For
1D.	ELECTION OF DIRECTOR: RICHARD C. MULLIGAN	Management	For	For
1E.	ELECTION OF DIRECTOR: ROBERT W. PANGIA	Management	For	For
1F.	ELECTION OF DIRECTOR: STELIOS PAPADOPOULOS	Management	For	For
1G.	ELECTION OF DIRECTOR: BRIAN S. POSNER	Management	For	For
1H.	ELECTION OF DIRECTOR: ERIC K. ROWINSKY	Management	For	For
1I.	ELECTION OF DIRECTOR: LYNN SCHENK	Management	For	For
1J.	ELECTION OF DIRECTOR: STEPHEN A. SHERWIN	Management	For	For
1K.	ELECTION OF DIRECTOR: MICHEL VOUNATSOS	Management	For	For
2.	TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS BIOGEN INC.’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For
3.	SAY ON PAY - TO APPROVE AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.	Management	For	For
4.	SAY WHEN ON PAY - TO APPROVE AN ADVISORY VOTE ON THE FREQUENCY OF THE ADVISORY VOTE ON EXECUTIVE COMPENSATION.	Management	1 Year	For
5.	TO APPROVE THE BIOGEN INC. 2017 OMNIBUS EQUITY PLAN.	Management	For	For

BIOMARIN PHARMACEUTICAL INC.

Security	09061G101	Meeting Type	Annual
Ticker Symbol	BMRN	Meeting Date	06-Jun-2017
Record Date	10-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1JEAN-JACQUES BIENAIME		For	For
	2WILLARD DERE		For	For
	3MICHAEL GREY		For	For
	4ELAINE J. HERON		For	For
	5V. BRYAN LAWLIS		For	For
	6ALAN J. LEWIS		For	For
	7RICHARD A. MEIER		For	For
	8DAVID PYOTT		For	For
	9DENNIS J. SLAMON		For	For
2.	TO RATIFY THE SELECTION OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR BIOMARIN FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For
3.	TO APPROVE, ON AN ADVISORY BASIS, THE FREQUENCY OF THE STOCKHOLDERS’ APPROVAL ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.	Management	1 Year	For
4.	TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.	Management	For	For
5.	TO APPROVE THE 2017 EQUITY INCENTIVE PLAN.	Management	For	For
6.	TO APPROVE AMENDMENTS TO BIOMARIN’S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO (I) INCREASE THE TOTAL NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 250,000,000 SHARES TO 500,000,000 SHARES, AND (II) MAKE CERTAIN MINOR ADMINISTRATIVE CHANGES.	Management	For	For

CARDINAL HEALTH, INC.

Security	14149Y108	Meeting Type	Annual
Ticker Symbol	CAH	Meeting Date	03-Nov-2016
Record Date	06-Sep-2016

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: DAVID J. ANDERSON	Management	For	For
1B.	ELECTION OF DIRECTOR: COLLEEN F. ARNOLD	Management	For	For
1C.	ELECTION OF DIRECTOR: GEORGE S. BARRETT	Management	For	For
1D.	ELECTION OF DIRECTOR: CARRIE S. COX	Management	For	For
1E.	ELECTION OF DIRECTOR: CALVIN DARDEN	Management	For	For
1F.	ELECTION OF DIRECTOR: BRUCE L. DOWNEY	Management	For	For
1G.	ELECTION OF DIRECTOR: PATRICIA A. HEMINGWAY HALL	Management	For	For
1H.	ELECTION OF DIRECTOR: CLAYTON M. JONES	Management	For	For
1I.	ELECTION OF DIRECTOR: GREGORY B. KENNY	Management	For	For
1J.	ELECTION OF DIRECTOR: NANCY KILLEFER	Management	For	For
1K.	ELECTION OF DIRECTOR: DAVID P. KING	Management	For	For
2.	PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT AUDITOR FOR THE FISCAL YEAR ENDING JUNE 30, 2017.	Management	For	For
3.	PROPOSAL TO APPROVE THE AMENDED CARDINAL HEALTH, INC. 2011 LONG-TERM INCENTIVE PLAN.	Management	For	For
4.	PROPOSAL TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.	Management	For	For

CARDIOKINETIX INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	20-Jun-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	NOTE FINANCING APPROVAL	Management	For	For
2.	WAIVER OF RIGHT OF FIRST OFFER	Management	For	For
3.	WAIVER OF ANTI-DILUTION ADJUSTMENTS	Management	For	For
4.	GENERAL AUTHROIZING RESOLUTIONS	Management	For	For

CARDIOKINETIX INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	21-Jun-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	CONSENT TO ASSIGNMENT BY THE STOCKHOLDERS	Management	For	For

CELGENE CORPORATION

Security	151020104	Meeting Type	Annual
Ticker Symbol	CELG	Meeting Date	14-Jun-2017
Record Date	20-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1ROBERT J. HUGIN		For	For
	2MARK J. ALLES		For	For
	3RICHARD W BARKER D PHIL		For	For
	4MICHAEL W. BONNEY		For	For
	5MICHAEL D. CASEY		For	For
	6CARRIE S. COX		For	For
	7MICHAEL A. FRIEDMAN, MD		For	For
	8JULIA A. HALLER, M.D.		For	For
	9GILLA S. KAPLAN, PH.D.		For	For
	10JAMES J. LOUGHLIN		For	For
	11ERNEST MARIO, PH.D.		For	For
2.	RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For
3.	APPROVAL OF AN AMENDMENT AND RESTATEMENT OF THE COMPANY’S STOCK INCENTIVE PLAN.	Management	For	For
4.	APPROVAL, BY NON-BINDING VOTE, OF EXECUTIVE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.	Management	For	For
5.	TO RECOMMEND, BY NON-BINDING VOTE, THE FREQUENCY OF EXECUTIVE COMPENSATION VOTES.	Management	1 Year	For
6.	STOCKHOLDER PROPOSAL TO REQUEST A BY-LAW PROVISION LIMITING MANAGEMENT’S ACCESS TO VOTE TALLIES PRIOR TO THE ANNUAL MEETING WITH RESPECT TO CERTAIN EXECUTIVE PAY MATTERS, DESCRIBED IN MORE DETAIL IN THE PROXY STATEMENT.	Shareholder	Against	For

CENTENE CORPORATION

Security	15135B101	Meeting Type	Annual
Ticker Symbol	CNC	Meeting Date	25-Apr-2017
Record Date	24-Feb-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: MICHAEL F. NEIDORFF	Management	For	For
1B.	ELECTION OF DIRECTOR: ROBERT K. DITMORE	Management	For	For
1C.	ELECTION OF DIRECTOR: RICHARD A. GEPHARDT	Management	For	For
2.	ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION.	Management	For	For
3.	APPROVAL OF AMENDMENT TO THE 2012 STOCK INCENTIVE PLAN.	Management	For	For
4.	ADVISORY VOTE ON FREQUENCY OF ADVISORY VOTE ON EXECUTIVE COMPENSATION.	Management	1 Year	For
5.	RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For

CHARLES RIVER LABORATORIES INTL., INC.

Security	159864107	Meeting Type	Annual
Ticker Symbol	CRL	Meeting Date	09-May-2017
Record Date	13-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: JAMES C. FOSTER	Management	For	For
1B.	ELECTION OF DIRECTOR: ROBERT J. BERTOLINI	Management	For	For
1C.	ELECTION OF DIRECTOR: STEPHEN D. CHUBB	Management	For	For
1D.	ELECTION OF DIRECTOR: DEBORAH T. KOCHEVAR	Management	For	For
1E.	ELECTION OF DIRECTOR: GEORGE E. MASSARO	Management	For	For
1F.	ELECTION OF DIRECTOR: GEORGE M. MILNE, JR.	Management	For	For
1G.	ELECTION OF DIRECTOR: C. RICHARD REESE	Management	For	For
1H.	ELECTION OF DIRECTOR: CRAIG B. THOMPSON	Management	For	For
1I.	ELECTION OF DIRECTOR: RICHARD F. WALLMAN	Management	For	For
2.	SAY ON PAY - AN ADVISORY VOTE TO APPROVE OUR EXECUTIVE COMPENSATION.	Management	For	For
3.	SAY WHEN ON PAY - AN ADVISORY VOTE ON THE APPROVAL OF THE FREQUENCY OF SHAREHOLDER VOTES ON EXECUTIVE COMPENSATION.	Management	1 Year	For
4.	APPROVAL OF INCENTIVE COMPENSATION PLAN.	Management	For	For
5.	RATIFICATION OF ACCOUNTANTS (PWC) (DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL)	Management	For	For
6.	SHAREHOLDER PROPOSAL SUBMITTED BY PETA TO PROHIBIT CONDUCTING BUSINESS WITH CERTAIN DEALERS AND LABORATORIES WHO VIOLATE THE ANIMAL WELFARE ACT OR ARE UNDER INVESTIGATION BY U.S. DEPARTMENT OF AGRICULTURE INVESTIGATIVE ENFORCEMENT SERVICES.	Shareholder	Against	For

COHERUS BIOSCIENCES INC

Security	19249H103	Meeting Type	Annual
Ticker Symbol	CHRS	Meeting Date	17-May-2017
Record Date	24-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1DENNIS M. LANFEAR		For	For
	2MATS WAHLSTROM		For	For
	3JAMES I. HEALY, MD, PHD		For	For
2.	TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For
3.	A NON-BINDING ADVISORY RESOLUTION TO APPROVE OUR EXECUTIVE COMPENSATION (A “SAY ON PAY” VOTE).	Management	For	For

CYTOMX THERAPEUTICS, INC.

Security	23284F105	Meeting Type	Annual
Ticker Symbol	CTMX	Meeting Date	20-Jun-2017
Record Date	28-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: NEIL EXTER	Management	For	For
1B.	ELECTION OF DIRECTOR: FREDERICK W. GLUCK	Management	For	For
1C.	ELECTION OF DIRECTOR: MATTHEW P. YOUNG	Management	For	For
2.	TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For

DERMIRA, INC.

Security	24983L104	Meeting Type	Annual
Ticker Symbol	DERM	Meeting Date	13-Jun-2017
Record Date	19-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1MARK D. MCDADE		For	For
	2JAKE R. NUNN		For	For
	3THOMAS G. WIGGANS		For	For
2.	APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION PAID BY US TO OUR NAMED EXECUTIVE OFFICERS FOR THE YEAR ENDED DECEMBER 31, 2016.	Management	For	For
3.	VOTE, ON A NON-BINDING ADVISORY BASIS, ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION.	Management	1 Year	For
4.	RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2017.	Management	For	For

DEXCOM, INC.

Security	252131107	Meeting Type	Annual
Ticker Symbol	DXCM	Meeting Date	31-May-2017
Record Date	07-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: RICHARD COLLINS	Management	For	For
1B.	ELECTION OF DIRECTOR: MARK FOLETTA	Management	For	For
1C.	ELECTION OF DIRECTOR: ERIC J. TOPOL	Management	For	For
2.	TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF OUR BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For
3.	ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION.	Management	For	For
4.	TO RECOMMEND A NON-BINDING ADVISORY RESOLUTION ON THE FREQUENCY OF STOCKHOLDER VOTES ON EXECUTIVE COMPENSATION.	Management	1 Year	For
5.	TO APPROVE OUR AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN.	Management	For	For
6.	TO APPROVE AN AMENDMENT TO DEXCOM’S RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 100 MILLION TO 200 MILLION.	Management	For	For

DYNEX TECHNOLOGIES, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	24-Mar-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	MERGER AGREEMENT AND OTHER TRANSACTIONS CONTEMPLATED THEREBY	Management	For	For
2.	TERMINATION OF STOCKHOLDERS AGREEMENT AND REGISTRATION RIGHTS AGREEMENT	Management	For	For
3.	APPROVAL UNDER SECTION 144 OF THE DGCL	Management	For	For
4.	WAIVER OF APPRAISAL RIGHTS	Management	For	For
5.	ADDITIONAL AGREEMENTS AND ACKNOWLEDGEMENTS	Management	For	For
6.	WAIVER OF NOTICE REQUIREMENTS	Management	For	For
7.	GENERAL AUTHORIZATION	Management	For	For

DYNEX TECHNOLOGIES, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	24-Mar-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	APPROVAL OF AMOUNTS PAYABLE TO THE EMPLOYEES PURSUANT TO THE ARRANGEMENTS (AS DESCRIBED IN THE INFORMATION STATEMENT) IN CONNECTION WITH THE PROPOSED TRANSACTION AND OTHER RELATED RESOLUTIONS	Management	For	For

ENDO INTERNATIONAL PLC

Security	G30401106	Meeting Type	Annual
Ticker Symbol	ENDP	Meeting Date	08-Jun-2017
Record Date	13-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: ROGER H. KIMMEL	Management	For	For
1B.	ELECTION OF DIRECTOR: PAUL V. CAMPANELLI	Management	For	For
1C.	ELECTION OF DIRECTOR: SHANE M. COOKE	Management	For	For
1D.	ELECTION OF DIRECTOR: NANCY J. HUTSON, PH.D.	Management	For	For
1E.	ELECTION OF DIRECTOR: MICHAEL HYATT	Management	For	For
1F.	ELECTION OF DIRECTOR: DOUGLAS S. INGRAM	Management	For	For
1G.	ELECTION OF DIRECTOR: WILLIAM P. MONTAGUE	Management	For	For
1H.	ELECTION OF DIRECTOR: TODD B. SISITSKY	Management	For	For
1I.	ELECTION OF DIRECTOR: JILL D. SMITH	Management	For	For
2.	TO APPROVE THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2017 AND TO AUTHORIZE THE BOARD OF DIRECTORS, ACTING THROUGH THE AUDIT COMMITTEE, TO DETERMINE THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S REMUNERATION.	Management	For	For
3.	TO APPROVE, BY ADVISORY VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.	Management	For	For
4.	TO APPROVE, BY ADVISORY VOTE, THE FREQUENCY OF FUTURE ADVISORY VOTES ON NAMED EXECUTIVE OFFICER COMPENSATION.	Management	1 Year	For
5.	TO APPROVE THE AMENDMENT OF THE COMPANY’S MEMORANDUM OF ASSOCIATION.	Management	For	For
6.	TO APPROVE THE AMENDMENT OF THE COMPANY’S ARTICLES OF ASSOCIATION.	Management	For	For
7.	TO APPROVE THE AMENDMENT OF THE COMPANY’S AMENDED AND RESTATED 2015 STOCK INCENTIVE PLAN.	Management	For	For

EPIZYME, INC.

Security	29428V104	Meeting Type	Annual
Ticker Symbol	EPZM	Meeting Date	22-Jun-2017
Record Date	24-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1ANDREW R ALLEN, MD, PHD		For	For
	2KENNETH BATE		For	For
	3ROBERT BAZEMORE		For	For
2.	RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS EPIZYME’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For

EUTHYMICS BIOSCIENCE, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	22-May-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	BRIDGE FINANCING	Management	For	For

EXELIXIS, INC.

Security	30161Q104	Meeting Type	Annual
Ticker Symbol	EXEL	Meeting Date	24-May-2017
Record Date	31-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: MICHAEL M. MORRISSEY, PH.D.	Management	For	For
1B.	ELECTION OF DIRECTOR: STELIOS PAPADOPOULOS, PH.D.	Management	For	For
1C.	ELECTION OF DIRECTOR: GEORGE A. SCANGOS, PH.D.	Management	For	For
1D.	ELECTION OF DIRECTOR: LANCE WILLSEY, M.D.	Management	For	For
2.	TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS EXELIXIS’ INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 29, 2017.	Management	For	For
3.	TO APPROVE THE EXELIXIS, INC. 2017 EQUITY INCENTIVE PLAN.	Management	For	For
4.	TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF EXELIXIS’ NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.	Management	For	For
5.	TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF STOCKHOLDER VOTES ON THE COMPENSATION OF EXELIXIS’ NAMED EXECUTIVE OFFICERS.	Management	1 Year	For

FLEX PHARMA INC

Security	33938A105	Meeting Type	Annual
Ticker Symbol	FLKS	Meeting Date	01-Jun-2017
Record Date	07-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1ROBERT PEREZ		For	For
	2STUART RANDLE		For	For
2.	TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For

FOAMIX PHARMACEUTICALS LTD

Security	M46135105	Meeting Type	Annual
Ticker Symbol	FOMX	Meeting Date	13-Jul-2017
Record Date	15-Jun-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	APPOINT KESSELMAN & KESSELMAN (PWC ISRAEL) AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR 2017, AND AUTHORIZE THE BOARD TO DETERMINE THE COMPENSATION OF THE AUDITORS.	Management	For	For
2.	RATIFY THE ELECTION OF DR. DALIA MEGIDDO AS A DIRECTOR OF THE COMPANY.	Management	For	For
3.	APPROVE THE TERMS OF COMPENSATION OF DR. STANLEY HIRSCH, OUR CHAIRMAN OF THE BOARD OF DIRECTORS, FOR THE YEAR 2016 AND ONWARD.	Management	For	For
4.	APPROVE THE AWARD OF ADDITIONAL OPTIONS AND RESTRICTED SHARE UNITS TO THE COMPANY’S NON- EXECUTIVE DIRECTORS.	Management	For	For
5.	APPROVE AN INCREASE OF THE AUTHORIZED SHARE CAPITAL OF THE COMPANY BY AN ADDITIONAL NIS 6,400,000 DIVIDED INTO 40,000,000 ORDINARY SHARES WITH A NOMINAL VALUE OF NIS 0.16 PER SHARE.	Management	Abstain	Against

GALAPAGOS N V

Security	36315X101	Meeting Type	Special
Ticker Symbol	GLPG	Meeting Date	26-Jul-2016
Record Date	08-Jul-2016

Item	Proposal	Proposed by	Vote	For/Against Mgmt
S1.	TO APPOINT MS. MARY KERR AS AN INDEPENDENT DIRECTOR OF THE COMPANY.	Management	For	For
E2.	AUTHORIZATION TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL WITHIN THEFRAMEWORK OF THE AUTHORIZED CAPITAL BY UP TO 40% OF THE SHARE CAPITAL.	Management	For	For

GALAPAGOS N V

Security	36315X101	Meeting Type	Annual
Ticker Symbol	GLPG	Meeting Date	25-Apr-2017
Record Date	20-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
O2	COMMUNICATION AND APPROVAL OF THE NON- CONSOLIDATED ANNUAL ACCOUNTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED ON 31 DECEMBER 2016 AND APPROVAL OF THE ALLOCATION OF THE ANNUAL RESULT AS PROPOSED BY THE BOARD OF DIRECTORS.	Management	For	For
O5	COMMUNICATION AND APPROVAL OF THE REMUNERATION REPORT.	Management	For	For
O6	RELEASE FROM LIABILITY TO BE GRANTED TO THE DIRECTORS AND THE STATUTORY AUDITOR FOR THE PERFORMANCE OF THEIR DUTIES IN THE COURSE OF THE FINANCIAL YEAR ENDED 31 DECEMBER 2016.	Management	For	For
O7	RATIFICATION OF THE STATUTORY AUDITOR’S REMUNERATION FOR THE FINANCIAL YEAR ENDED ON 31 DECEMBER 2016.	Management	For	For
O8	RE-APPOINTMENT OF STATUTORY AUDITOR AND DETERMINATION OF STATUTORY AUDITOR’S REMUNERATION.	Management	For	For
O9A	RE-APPOINTMENT OF MR. ONNO VAN DE STOLPE AS DIRECTOR OF THE COMPANY.	Management	For	For
O9B	RE-APPOINTMENT OF DR. RAJ PAREKH AS DIRECTOR OF THE COMPANY.	Management	For	For
O9C	RE-APPOINTMENT OF MS. KATRINE BOSLEY AS INDEPENDENT DIRECTOR OF THE COMPANY.	Management	For	For
O10	REMUNERATION OF DIRECTORS.	Management	For	For
O11	OFFER OF WARRANTS.	Management	For	For
O12	APPLICATION OF ARTICLE 556 OF THE BELGIAN COMPANIES CODE.	Management	For	For
E2	AUTHORIZATION TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL WITHIN THE FRAMEWORK OF THE AUTHORIZED CAPITAL BY UP TO 20% OF THE SHARE CAPITAL.	Management	For	For
E3	AUTHORIZATION TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL WITHIN THE FRAMEWORK OF THE AUTHORIZED CAPITAL BY UP TO 33% OF THE SHARE CAPITAL, IN SPECIFIC CIRCUMSTANCES.	Management	For	For

GENOMEDX BIOSCIENCES INC.

Security	N/A	Meeting Type	Special
Ticker Symbol	N/A	Meeting Date	24-Jan-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	AUTHORIZED SHARE STRUCTURE AMENDEMENT RESOLUTION	Management	For	For
2.	SPECIAL RIGHTS AND RESTRICTIONS RESOLUTION	Management	For	For
3.	CLASS C PREFERRED SHARE ISSUANCE RESOLUTION	Management	For	For

GENOMEDX BIOSCIENCES INC.

Security	N/A	Meeting Type	Special
Ticker Symbol	N/A	Meeting Date	30-Jun-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	AUDITOR RESOLUTION	Management	For	For
2.	ELECTION OF DIRECTORS	Management	For	For
3.	AMENDMENTS TO STOCK OPTION PLAN	Management	For	For

GILEAD SCIENCES, INC.

Security	375558103	Meeting Type	Annual
Ticker Symbol	GILD	Meeting Date	10-May-2017
Record Date	16-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: JOHN F. COGAN, PH.D.	Management	For	For
1B.	ELECTION OF DIRECTOR: KELLY A. KRAMER	Management	For	For
1C.	ELECTION OF DIRECTOR: KEVIN E. LOFTON	Management	For	For
1D.	ELECTION OF DIRECTOR: JOHN C. MARTIN, PH.D.	Management	For	For
1E.	ELECTION OF DIRECTOR: JOHN F. MILLIGAN, PH.D.	Management	For	For
1F.	ELECTION OF DIRECTOR: NICHOLAS G. MOORE	Management	For	For
1G.	ELECTION OF DIRECTOR: RICHARD J. WHITLEY, M.D	Management	For	For
1H.	ELECTION OF DIRECTOR: GAYLE E. WILSON	Management	For	For
1I.	ELECTION OF DIRECTOR: PER WOLD-OLSEN	Management	For	For
2.	RATIFICATION OF THE SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.	Management	For	For
3.	RESTATEMENT OF THE GILEAD SCIENCES, INC. 2004 EQUITY INCENTIVE PLAN.	Management	For	For
4.	ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.	Management	For	For
5.	ADVISORY VOTE AS TO THE FREQUENCY OF FUTURE ADVISORY SHAREHOLDER VOTES ON EXECUTIVE COMPENSATION.	Management	1 Year	For
6.	STOCKHOLDER PROPOSAL REQUESTING THAT THE BOARD TAKE STEPS TO PERMIT STOCKHOLDER ACTION BY WRITTEN CONSENT.	Shareholder	Against	For
7.	STOCKHOLDER PROPOSAL REQUESTING THAT THE BOARD ADOPT A POLICY THAT THE CHAIRMAN OF THE BOARD OF DIRECTORS BE AN INDEPENDENT DIRECTOR.	Shareholder	Against	For

IDEXX LABORATORIES, INC.

Security	45168D104	Meeting Type	Annual
Ticker Symbol	IDXX	Meeting Date	03-May-2017
Record Date	10-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: REBECCA M. HENDERSON, PHD	Management	For	For
1B.	ELECTION OF DIRECTOR: LAWRENCE D. KINGSLEY	Management	For	For
1C.	ELECTION OF DIRECTOR: SOPHIE V. VANDEBROEK, PHD	Management	For	For
2.	RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR (PROPOSAL TWO).	Management	For	For
3.	ADVISORY VOTE ON EXECUTIVE COMPENSATION. TO APPROVE A NONBINDING ADVISORY RESOLUTION ON THE COMPANY’S EXECUTIVE COMPENSATION (PROPOSAL THREE).	Management	For	For
4.	ADVISORY VOTE ON THE FREQUENCY OF ADVISORY VOTES ON EXECUTIVE COMPENSATION. TO RECOMMEND, BY NONBINDING ADVISORY VOTE, THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPANY’S EXECUTIVE COMPENSATION (PROPOSAL FOUR).	Management	1 Year	For

ILLUMINA, INC.

Security	452327109	Meeting Type	Annual
Ticker Symbol	ILMN	Meeting Date	30-May-2017
Record Date	07-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: CAROLINE D. DORSA	Management	For	For
1B.	ELECTION OF DIRECTOR: ROBERT S. EPSTEIN, M.D.	Management	For	For
1C.	ELECTION OF DIRECTOR: PHILIP W. SCHILLER	Management	For	For
2.	TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For
3.	TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.	Management	For	For
4.	TO RECOMMEND, BY NON-BINDING VOTE, THE FREQUENCY OF EXECUTIVE COMPENSATION VOTES.	Management	1 Year	For
5.	TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO REMOVE CERTAIN SUPERMAJORITY VOTING REQUIREMENTS AS DISCLOSED IN THE PROXY STATEMENT.	Management	For	For

ILLUMINOSS MEDICAL, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	28-Mar-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	CONVERTIBLE NOTE FINANCING	Management	For	For
2.	ANTI-DILUTION	Management	For	For
3.	GENERAL RESOLUTIONS	Management	For	For

IMPAX LABORATORIES, INC.

Security	45256B101	Meeting Type	Annual
Ticker Symbol	IPXL	Meeting Date	16-May-2017
Record Date	27-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: LESLIE Z. BENET, PH.D.	Management	For	For
1B.	ELECTION OF DIRECTOR: RICHARD A. BIERLY	Management	For	For
1C.	ELECTION OF DIRECTOR: PAUL M. BISARO	Management	For	For
1D.	ELECTION OF DIRECTOR: J. KEVIN BUCHI	Management	For	For
1E.	ELECTION OF DIRECTOR: ROBERT L. BURR	Management	For	For
1F.	ELECTION OF DIRECTOR: ALLEN CHAO, PH.D.	Management	For	For
1G.	ELECTION OF DIRECTOR: MARY K. PENDERGAST, J.D.	Management	For	For
1H.	ELECTION OF DIRECTOR: PETER R. TERRERI	Management	For	For
1I.	ELECTION OF DIRECTOR: JANET S. VERGIS	Management	For	For
2.	TO APPROVE THE A&R OF OUR NON-QUALIFIED ESPP ...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL)	Management	For	For
3.	TO APPROVE THE FOURTH A&R OF OUR 2002 EQUITY INCENTIVE PLAN ...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL)	Management	For	For
4.	TO APPROVE, BY NON-BINDING VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.	Management	For	For
5.	TO APPROVE, BY NON-BINDING VOTE, THE FREQUENCY OF NAMED EXECUTIVE OFFICER COMPENSATION VOTES.	Management	1 Year	For
6.	TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT ..(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL)	Management	For	For

INCYTE CORPORATION

Security	45337C102	Meeting Type	Annual
Ticker Symbol	INCY	Meeting Date	26-May-2017
Record Date	07-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1JULIAN C. BAKER		For	For
	2JEAN-JACQUES BIENAIME		For	For
	3PAUL A. BROOKE		For	For
	4PAUL J. CLANCY		For	For
	5WENDY L. DIXON		For	For
	6PAUL A. FRIEDMAN		For	For
	7HERVE HOPPENOT		For	For
2.	TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.	Management	For	For
3.	TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE FREQUENCY OF FUTURE NON-BINDING ADVISORY STOCKHOLDER VOTES ON THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.	Management	1 Year	For
4.	TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2017.	Management	For	For

INNOVIVA INC

Security	45781M101	Meeting Type	Contested-Annual
Ticker Symbol	INVA	Meeting Date	20-Apr-2017
Record Date	24-Feb-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1MICHAEL W. AGUIAR		For	For
	2BARBARA DUNCAN		For	For
	3CATHERINE J. FRIEDMAN		For	For
	4PATRICK G. LEPORE		For	For
	5PAUL A. PEPE		For	For
	6JAMES L. TYREE		For	For
	7WILLIAM H. WALTRIP		For	For
2.	APPROVE AN ADVISORY NON-BINDING RESOLUTION REGARDING EXECUTIVE COMPENSATION.	Management	For	For
3.	APPROVE AN ADVISORY NON-BINDING RESOLUTION ON THE FREQUENCY OF HOLDING AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.	Management	1 Year	For
4.	RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS FOR ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For
5.	VOTE ON A STOCKHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE ANNUAL MEETING, TO REPEAL CERTAIN PROVISIONS OF THE COMPANY’S BYLAWS.	Shareholder	For	Against

ISHARES TRUST

Security	464287556	Meeting Type	Special
Ticker Symbol	IBB	Meeting Date	19-Jun-2017
Record Date	02-May-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1JANE D. CARLIN		For	For
	2RICHARD L. FAGNANI		For	For
	3DREW E. LAWTON		For	For
	4MADHAV V. RAJAN		For	For
	5MARK WIEDMAN		For	For

JAZZ PHARMACEUTICALS PLC

Security	G50871105	Meeting Type	Annual
Ticker Symbol	JAZZ	Meeting Date	04-Aug-2016
Record Date	07-Jun-2016

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: PAUL L. BERNS	Management	For	For
1B.	ELECTION OF DIRECTOR: PATRICK G. ENRIGHT	Management	For	For
1C.	ELECTION OF DIRECTOR: SEAMUS MULLIGAN	Management	For	For
1D.	ELECTION OF DIRECTOR: NORBERT G. RIEDEL, PH.D.	Management	For	For
2.	TO RATIFY, ON A NON-BINDING ADVISORY BASIS, THE APPOINTMENT OF KPMG, DUBLIN AS THE INDEPENDENT AUDITORS OF JAZZ PHARMACEUTICALS PLC FOR THE FISCAL YEAR ENDING DECEMBER 31, 2016 AND TO AUTHORIZE, IN A BINDING VOTE, THE BOARD OF DIRECTORS, ACTING THROUGH THE AUDIT COMMITTEE, TO DETERMINE THE AUDITORS’ REMUNERATION.	Management	For	For
3.	TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF JAZZ PHARMACEUTICALS PLC’S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.	Management	For	For
4A.	TO APPROVE AMENDMENTS TO JAZZ PHARMACEUTICALS PLC’S MEMORANDUM OF ASSOCIATION TO MAKE CERTAIN ADMINISTRATIVE ADJUSTMENTS TO ADDRESS THE ENACTMENT OF THE IRISH COMPANIES ACT 2014 AND A MINOR HOUSEKEEPING MATTER.	Management	For	For
4B.	TO APPROVE AMENDMENTS TO JAZZ PHARMACEUTICALS PLC’S ARTICLES OF ASSOCIATION TO MAKE CERTAIN ADMINISTRATIVE ADJUSTMENTS TO ADDRESS THE ENACTMENT OF THE IRISH COMPANIES ACT 2014 AND CERTAIN MINOR HOUSEKEEPING MATTERS.	Management	For	For
5.	TO AUTHORIZE JAZZ PHARMACEUTICALS PLC AND/OR ANY SUBSIDIARY OF JAZZ PHARMACEUTICALS PLC TO MAKE OPEN MARKET PURCHASES OF JAZZ PHARMACEUTICALS PLC’S ORDINARY SHARES.	Management	For	For
6.	TO RENEW THE BOARD OF DIRECTORS’ EXISTING AUTHORITY UNDER IRISH LAW TO ALLOT AND ISSUE ORDINARY SHARES.	Management	For	For
7.	TO RENEW THE BOARD OF DIRECTORS’ EXISTING AUTHORITY UNDER IRISH LAW TO ALLOT AND ISSUE ORDINARY SHARES FOR CASH WITHOUT FIRST OFFERING THOSE ORDINARY SHARES TO EXISTING SHAREHOLDERS PURSUANT TO THE STATUTORY PRE-EMPTION RIGHT THAT WOULD OTHERWISE APPLY.	Management	For	For
8.	TO APPROVE ANY MOTION TO ADJOURN THE ANNUAL MEETING, OR ANY ADJOURNMENTS THEREOF, TO ANOTHER TIME AND PLACE TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE ANNUAL MEETING TO APPROVE ANY OR ALL OF PROPOSALS 4A, 4B AND/OR 7.	Management	For	For
9.	TO APPROVE AN AMENDMENT AND RESTATEMENT OF JAZZ PHARMACEUTICALS PLC’S 2011 EQUITY INCENTIVE PLAN IN ORDER TO RENEW JAZZ PHARMACEUTICALS PLC’S ABILITY TO GRANT AWARDS THEREUNDER THAT MAY QUALIFY AS “PERFORMANCE-BASED COMPENSATION” UNDER SECTION 162(M) OF THE U.S. INTERNAL REVENUE CODE.	Management	For	For
10.	TO APPROVE AN AMENDMENT AND RESTATEMENT OF JAZZ PHARMACEUTICALS PLC’S AMENDED AND RESTATED 2007 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN IN ORDER TO (I) EXPAND THE TYPES OF STOCK AWARDS THAT MAY BE GRANTED THEREUNDER TO JAZZ PHARMACEUTICALS PLC’S NON-EMPLOYEE DIRECTORS AND (II) ELIMINATE THE FINAL AUTOMATIC ANNUAL INCREASE TO THE SHARE RESERVE THAT IS OTHERWISE SCHEDULED TO OCCUR IN 2017 PURSUANT TO THE “EVERGREEN” PROVISION INCLUDED THEREIN.	Management	For	For

JAZZ PHARMACEUTICALS PLC

Security	G50871105	Meeting Type	Annual
Ticker Symbol	JAZZ	Meeting Date	03-Aug-2017
Record Date	07-Jun-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: BRUCE C. COZADD	Management	For	For
1B.	ELECTION OF DIRECTOR: HEATHER ANN MCSHARRY	Management	For	For
1C.	ELECTION OF DIRECTOR: RICK E WINNINGHAM	Management	For	For
2.	TO RATIFY, ON A NON-BINDING ADVISORY BASIS, THE APPOINTMENT OF KPMG, DUBLIN AS THE INDEPENDENT AUDITORS OF JAZZ PHARMACEUTICALS PLC FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017 AND TO AUTHORIZE, IN A BINDING VOTE, THE BOARD OF DIRECTORS, ACTING THROUGH THE AUDIT COMMITTEE, TO DETERMINE THE AUDITORS’ REMUNERATION.	Management	For	For
3.	TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF JAZZ PHARMACEUTICALS PLC’S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT.	Management	For	For
4.	TO AUTHORIZE JAZZ PHARMACEUTICALS PLC AND/OR ANY SUBSIDIARY OF JAZZ PHARMACEUTICALS PLC TO MAKE OPEN MARKET PURCHASES OF JAZZ PHARMACEUTICALS PLC’S ORDINARY SHARES.	Management	For	For

MCKESSON CORPORATION

Security	58155Q103	Meeting Type	Annual
Ticker Symbol	MCK	Meeting Date	27-Jul-2016
Record Date	31-May-2016

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: ANDY D. BRYANT	Management	For	For
1B.	ELECTION OF DIRECTOR: WAYNE A. BUDD	Management	For	For
1C.	ELECTION OF DIRECTOR: N. ANTHONY COLES, M.D.	Management	For	For
1D.	ELECTION OF DIRECTOR: JOHN H. HAMMERGREN	Management	For	For
1E.	ELECTION OF DIRECTOR: M. CHRISTINE JACOBS	Management	For	For
1F.	ELECTION OF DIRECTOR: DONALD R. KNAUSS	Management	For	For
1G.	ELECTION OF DIRECTOR: MARIE L. KNOWLES	Management	For	For
1H.	ELECTION OF DIRECTOR: EDWARD A. MUELLER	Management	For	For
1I.	ELECTION OF DIRECTOR: SUSAN R. SALKA	Management	For	For
2.	RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING MARCH 31, 2017.	Management	For	For
3.	ADVISORY VOTE ON EXECUTIVE COMPENSATION.	Management	For	For
4.	SHAREHOLDER PROPOSAL ON ACCELERATED VESTING OF EQUITY AWARDS.	Shareholder	Against	For
5.	SHAREHOLDER PROPOSAL ON DISCLOSURE OF POLITICAL CONTRIBUTIONS AND EXPENDITURES.	Shareholder	Against	For

MEDIVATION, INC.

Security	58501N101	Meeting Type	Contested-Consent
Ticker Symbol	MDVN	Meeting Date	06-Jul-2016
Record Date	01-Jun-2016

Item	Proposal	Proposed by	Vote	For/Against Mgmt
01	THAT ANY CHANGES TO THE AMENDED AND RESTATED BYLAWS OF THE COMPANY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON FEBRUARY 13, 2015 (THE “MEDIVATION BYLAWS”) BE REPEALED; A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
02	THAT SECTION 17(A) OF ARTICLE IV OF THE MEDIVATION BYLAWS BE AMENDED TO EXPRESSLY PROVIDE THAT ANY VACANCIES ON THE BOARD OF DIRECTORS OF MEDIVATION (THE “BOARD”) MAY BE FILLED BY THE STOCKHOLDERS OF THE COMPANY AND THOSE VACANCIES ON THE BOARD RESULTING FROM A REMOVAL OF DIRECTORS BY THE STOCKHOLDERS SHALL BE FILLED EXCLUSIVELY BY THE STOCKHOLDERS. A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
3A	REMOVAL OF DIRECTOR: KIM D. BLICKENSTAFF A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
3B	REMOVAL OF DIRECTOR: KATHRYN E. FALBERG A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
3C	REMOVAL OF DIRECTOR: DAVID T. HUNG A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
3D	REMOVAL OF DIRECTOR: MICHAEL L. KING A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
3E	REMOVAL OF DIRECTOR: C. PATRICK MACHADO A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
3F	REMOVAL OF DIRECTOR: DAWN SVORONOS A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
3G	REMOVAL OF DIRECTOR: W. ANTHONY VERNON A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
3H	REMOVAL OF DIRECTOR: WENDY L. YARNO A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
4A	ELECTION OF DIRECTOR: MICHAEL E. CAMPBELL A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
4B	ELECTION OF DIRECTOR: BARBARA DEPTULA A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
4C	ELECTION OF DIRECTOR: WENDY E. LANE A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
4D	ELECTION OF DIRECTOR: RONALD S. ROLFE A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
4E	ELECTION OF DIRECTOR: STEVEN J. SHULMAN A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
4F	ELECTION OF DIRECTOR: CHARLES P. SLACIK A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
4G	ELECTION OF DIRECTOR: JAMES L. TYREE A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For
4H	ELECTION OF DIRECTOR: DAVID A. WILSON A “FOR” OR “ABSTAIN” VOTE IS A VOTE TO REVOKE CONSENT	Management	For	For

MERCK & CO., INC.

Security	58933Y105	Meeting Type	Annual
Ticker Symbol	MRK	Meeting Date	23-May-2017
Record Date	27-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: LESLIE A. BRUN	Management	For	For
1B.	ELECTION OF DIRECTOR: THOMAS R. CECH	Management	For	For
1C.	ELECTION OF DIRECTOR: PAMELA J. CRAIG	Management	For	For
1D.	ELECTION OF DIRECTOR: KENNETH C. FRAZIER	Management	For	For
1E.	ELECTION OF DIRECTOR: THOMAS H. GLOCER	Management	For	For
1F.	ELECTION OF DIRECTOR: ROCHELLE B. LAZARUS	Management	For	For
1G.	ELECTION OF DIRECTOR: JOHN H. NOSEWORTHY	Management	For	For
1H.	ELECTION OF DIRECTOR: CARLOS E. REPRESAS	Management	For	For
1I.	ELECTION OF DIRECTOR: PAUL B. ROTHMAN	Management	For	For
1J.	ELECTION OF DIRECTOR: PATRICIA F. RUSSO	Management	For	For
1K.	ELECTION OF DIRECTOR: CRAIG B. THOMPSON	Management	For	For
1L.	ELECTION OF DIRECTOR: WENDELL P. WEEKS	Management	For	For
1M.	ELECTION OF DIRECTOR: PETER C. WENDELL	Management	For	For
2.	NON-BINDING ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.	Management	For	For
3.	NON-BINDING ADVISORY VOTE ON THE FREQUENCY OF FUTURE VOTES TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.	Management	1 Year	For
4.	RATIFICATION OF THE APPOINTMENT OF THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2017.	Management	For	For
5.	SHAREHOLDER PROPOSAL REQUESTING AN INDEPENDENT BOARD CHAIRMAN.	Shareholder	Against	For
6.	SHAREHOLDER PROPOSAL REQUESTING IMPLEMENTATION OF A SET OF EMPLOYEE PRACTICES IN ISRAEL/PALESTINE.	Shareholder	Against	For
7.	SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CONDUCTING BUSINESS IN CONFLICT-AFFECTED AREAS.	Shareholder	Against	For
8.	SHAREHOLDER PROPOSAL REQUESTING A REPORT ON BOARD OVERSIGHT OF PRODUCT SAFETY AND QUALITY.	Shareholder	Against	For

MERUS N.V.

Security	N5749R100	Meeting Type	Annual
Ticker Symbol	MRUS	Meeting Date	24-May-2017
Record Date	26-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	ADOPTION OF THE ANNUAL ACCOUNTS OVER THE FINANCIAL YEAR 2016	Management	For	For
2.	APPOINTMENT OF THE EXTERNAL AUDITOR FOR THE FINANCIAL YEAR 2017	Management	For	For
3.	RELEASE OF THE MANAGEMENT DIRECTORS FROM LIABILITY FOR THE EXERCISE OF THEIR DUTIES DURING THE FINANCIAL YEAR 2016	Management	For	For
4.	RELEASE OF THE SUPERVISORY DIRECTORS FROM LIABILITY FOR THE EXERCISE OF THEIR DUTIES DURING THE FINANCIAL YEAR 2016	Management	For	For
5.	(I) AMENDMENT OF THE COMPANY’S ARTICLES OF ASSOCIATION, (II) AUTHORIZATION TO IMPLEMENT SUCH AMENDMENT AND (III) DESIGNATION OF MANAGING AND SUPERVISORY DIRECTORS AS EXECUTIVE AND NON-EXECUTIVE DIRECTORS	Management	For	For
6.	REAPPOINTMENT OF DR. W. BERTHOLD, PH.D. AND DESIGNATION AS NON-EXECUTIVE DIRECTOR	Management	For	For
7.	REAPPOINTMENT OF DR. J.P. DE KONING, PH.D. AND DESIGNATION AS NON-EXECUTIVE DIRECTOR	Management	For	For
8.	AMENDMENT OF THE COMPANY’S COMPENSATION POLICY	Management	For	For
9.	AMENDMENT OF THE COMPANY’S SUPERVISORY BOARD MEMBER COMPENSATION PROGRAM	Management	For	For
10.	APPROVAL OF THE INCREASE OF THE GRANT DATE FAIR VALUE OF EQUITY AWARDS UNDER THE COMPANY’S SUPERVISORY BOARD MEMBER COMPENSATION PROGRAM	Management	For	For
11.	GRANTING OF EQUITY COMPENSATION TO MR. M.T. IWICKI	Management	For	For
12.	GRANTING OF EQUITY COMPENSATION TO DR. W. BERTHOLD, PH.D.	Management	For	For
13.	GRANTING OF EQUITY COMPENSATION TO MR. L.M.S. CARNOT	Management	For	For
14.	GRANTING OF EQUITY COMPENSATION TO DR. J.P. DE KONING, PH.D.	Management	For	For
15.	GRANTING OF EQUITY COMPENSATION TO DR. A. MEHRA, M.D.	Management	For	For
16.	GRANTING OF EQUITY COMPENSATION TO MR. G.D. PERRY	Management	For	For
17.	APPROVAL OF AMENDMENT TO AWARDS GRANTED UNDER THE COMPANY’S 2010 EMPLOYEE OPTION PLAN	Management	For	For
18.	GRANTING AUTHORIZATION OF THE MANAGEMENT BOARD TO ISSUE SHARES AND TO GRANT RIGHTS TO SUBSCRIBE FOR SHARES	Management	For	For
19.	GRANTING AUTHORIZATION OF THE MANAGEMENT BOARD TO LIMIT OR EXCLUDE PRE-EMPTION RIGHTS	Management	For	For
20.	GRANTING AUTHORIZATION OF THE MANAGEMENT BOARD TO ACQUIRE SHARES IN THE COMPANY’S CAPITAL	Management	For	For

MOLINA HEALTHCARE, INC.

Security	60855R100	Meeting Type	Annual
Ticker Symbol	MOH	Meeting Date	10-May-2017
Record Date	09-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: DR. J. MARIO MOLINA	Management	For	For
1B.	ELECTION OF DIRECTOR: RONNA E. ROMNEY	Management	For	For
1C.	ELECTION OF DIRECTOR: DALE B. WOLF	Management	For	For
2.	TO CONSIDER AND APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.	Management	For	For
3.	TO CONDUCT AN ADVISORY VOTE ON THE FREQUENCY OF A STOCKHOLDER VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.	Management	1 Year	For
4.	TO APPROVE AN AMENDMENT AND RESTATEMENT OF THE MOLINA HEALTHCARE, INC. 2011 EQUITY INCENTIVE PLAN (THE “EQUITY INCENTIVE PLAN”) AND RE-APPROVE THE MATERIAL TERMS OF THE PERFORMANCE GOALS FOR SECTION 162(M)(1) AWARDS UNDER THE EQUITY INCENTIVE PLAN.	Management	For	For
5.	TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2017.	Management	For	For

MYLAN N.V.

Security	N59465109	Meeting Type	Annual
Ticker Symbol	MYL	Meeting Date	22-Jun-2017
Record Date	25-May-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: HEATHER BRESCH	Management	Against	Against
1B.	ELECTION OF DIRECTOR: WENDY CAMERON	Management	Against	Against
1C.	ELECTION OF DIRECTOR: HON. ROBERT J. CINDRICH	Management	For	For
1D.	ELECTION OF DIRECTOR: ROBERT J. COURY	Management	Against	Against
1E.	ELECTION OF DIRECTOR: JOELLEN LYONS DILLON	Management	For	For
1F.	ELECTION OF DIRECTOR: NEIL DIMICK, C.P.A.	Management	Against	Against
1G.	ELECTION OF DIRECTOR: MELINA HIGGINS	Management	For	For
1H.	ELECTION OF DIRECTOR: RAJIV MALIK	Management	For	For
1I.	ELECTION OF DIRECTOR: MARK W. PARRISH	Management	Against	Against
1J.	ELECTION OF DIRECTOR: RANDALL L. (PETE) VANDERVEEN, PH.D., R.PH.	Management	For	For
1K.	ELECTION OF DIRECTOR: SJOERD S. VOLLEBREGT	Management	For	For
2.	ADOPTION OF THE DUTCH ANNUAL ACCOUNTS FOR FISCAL YEAR 2016	Management	For	For
3.	RATIFICATION OF THE SELECTION OF DELOITTE & TOUCHE LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR 2017	Management	For	For
4.	INSTRUCTION TO DELOITTE ACCOUNTANTS B.V. FOR THE AUDIT OF THE COMPANY’S DUTCH STATUTORY ANNUAL ACCOUNTS FOR FISCAL YEAR 2017	Management	For	For
5.	APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS OF THE COMPANY (THE “SAY-ON-PAY VOTE”)	Management	Against	Against
6.	ADVISORY VOTE ON THE FREQUENCY OF THE SAY-ON-PAY VOTE	Management	1 Year	For
7.	AUTHORIZATION OF THE MYLAN BOARD TO ACQUIRE ORDINARY SHARES AND PREFERRED SHARES IN THE CAPITAL OF THE COMPANY	Management	For	For

NATERA, INC.

Security	632307104	Meeting Type	Annual
Ticker Symbol	NTRA	Meeting Date	23-May-2017
Record Date	31-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1HERM ROSENMAN		For	For
	2JOHN STEUART		For	For
	3JONATHAN SHEENA		For	For
2.	PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For

NEUROCRINE BIOSCIENCES, INC.

Security	64125C109	Meeting Type	Annual
Ticker Symbol	NBIX	Meeting Date	22-May-2017
Record Date	31-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1KEVIN C. GORMAN, PH.D.		For	For
	2GARY A. LYONS		For	For
	3A W SANDROCK JR MD, PHD		For	For
2.	ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS.	Management	For	For
3.	AN ADVISORY VOTE ON THE FREQUENCY OF ADVISORY VOTING ON THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS.	Management	1 Year	For
4.	TO APPROVE AN AMENDMENT TO THE COMPANY’S 2011 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE THEREUNDER FROM 15,500,000 TO 17,000,000.	Management	For	For
5.	TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For

NEUROVANCE, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	05-Aug-2016
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	ENGAGEMENT LETTER WITH JEFFERIES	Management	For	For

NEUROVANCE, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	08-Aug-2016
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	BRIDGE FINANCING	Management	For	For

NEUROVANCE, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	17-Nov-2016
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	BRIDGE FINANCING	Management	For	For

NEUROVANCE, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	16-Dec-2016
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	BRIDGE FINANCING	Management	For	For
2.	SERVICE PROVIDER CONVERTIBLE NOTE	Management	For	For
3.	INTERCOMPANY ADJUSTMENTS	Management	For	For

NEUROVANCE, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	16-Dec-2016
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	EMPLOYMENT AND OPTION AGREEMENTS	Management	For	For
2.	AMENDING CHARTER AND INCENTIVE STOCK PLAN EXPANSION	Management	For	For
3.	ADDING MR. BRIAN GOFF TO BOARD OF DIRECTORS	Management	For	For
4.	AMENDING CHARTER AND INCENTIVE STOCK PLAN EXPANSION	Management	For	For
5.	GENERAL; IMPLEMENTATION	Management	For	For

NEUROVANCE, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	14-Feb-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	BRIDGE FINANCING	Management	For	For

NEUROVANCE, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	09-Mar-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DECLARATION OF DIVIDEND	Management	For	For

NEUROVANCE, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	13-Mar-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	APPROVAL OF POTENTIAL PARACHUTE PAYMENTS TO EXECUTIVES	Management	For	For

NEUROVANCE, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	13-Mar-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	APPROVAL OF MERGER AGREEMENT AND RELATED DOCUMENTS	Management	For	For
2.	APPROVAL OF SECURITYHOLDERS’ REPRESENTATIVE	Management	For	For
3.	TERMINATION OF STOCKHOLDER AGREEMENTS	Management	For	For
4.	WAIVER OF APPRAISAL RIGHTS	Management	For	For
5.	GENERAL AUTHORITY	Management	For	For

OVID THERAPEUTICS INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	04-Jan-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	APPROVAL OF ISSUANCE OF SERIES B-1 PREFERRED STOCK	Management	For	For
2.	AMENDMENT AND RESTATEMENT OF THE CERTIFICATE OF INCORPORATION	Management	For	For
3.	GENERAL	Management	For	For

OVID THERAPEUTICS INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	24-Apr-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - REVERSE STOCK SPLIT	Management	For	For
2.	INDEMNITY AGREEMENTS	Management	For	For
3.	GENERAL	Management	For	For

OVID THERAPEUTICS INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	24-Apr-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	IPO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION	Management	For	For
2.	APPROVAL OF 2017 EQUITY INCENTIVE PLAN	Management	For	For
3.	APPROVAL OF 2017 EMPLOYEE STOCK PURCHASE PLAN	Management	For	For
4.	GENERAL	Management	For	For

PARATEK PHARMACEUTICALS, INC.

Security	699374302	Meeting Type	Annual
Ticker Symbol	PRTK	Meeting Date	15-Jun-2017
Record Date	17-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1MICHAEL F. BIGHAM		For	For
	2ROBERT S. RADIE		For	For
2.	TO CONSIDER AND APPROVE A NON-BINDING ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.	Management	For	For
3.	TO HOLD A NON-BINDING ADVISORY VOTE ON THE FREQUENCY OF HOLDING FUTURE NON-BINDING ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.	Management	3 Years	For
4.	TO CONSIDER AND APPROVE THE PARATEK PHARMACEUTICALS, INC. ANNUAL INCENTIVE PLAN.	Management	For	For
5.	TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2017.	Management	For	For

PFIZER INC.

Security	717081103	Meeting Type	Annual
Ticker Symbol	PFE	Meeting Date	27-Apr-2017
Record Date	28-Feb-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: DENNIS A. AUSIELLO	Management	For	For
1B.	ELECTION OF DIRECTOR: RONALD E. BLAYLOCK	Management	For	For
1C.	ELECTION OF DIRECTOR: W. DON CORNWELL	Management	For	For
1D.	ELECTION OF DIRECTOR: JOSEPH J. ECHEVARRIA	Management	For	For
1E.	ELECTION OF DIRECTOR: FRANCES D. FERGUSSON	Management	For	For
1F.	ELECTION OF DIRECTOR: HELEN H. HOBBS	Management	For	For
1G.	ELECTION OF DIRECTOR: JAMES M. KILTS	Management	For	For
1H.	ELECTION OF DIRECTOR: SHANTANU NARAYEN	Management	For	For
1I.	ELECTION OF DIRECTOR: SUZANNE NORA JOHNSON	Management	For	For
1J.	ELECTION OF DIRECTOR: IAN C. READ	Management	For	For
1K.	ELECTION OF DIRECTOR: STEPHEN W. SANGER	Management	For	For
1L.	ELECTION OF DIRECTOR: JAMES C. SMITH	Management	For	For
2.	RATIFY THE SELECTION OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2017	Management	For	For
3.	ADVISORY APPROVAL OF EXECUTIVE COMPENSATION	Management	For	For
4.	ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION	Management	1 Year	For
5.	SHAREHOLDER PROPOSAL REGARDING THE HOLY LAND PRINCIPLES	Shareholder	Against	For
6.	SHAREHOLDER PROPOSAL REGARDING SPECIAL SHAREOWNER MEETINGS	Shareholder	Against	For
7.	SHAREHOLDER PROPOSAL REGARDING INDEPENDENT CHAIR POLICY	Shareholder	Against	For

PIERIS PHARMACEUTICALS INC

Security	720795103	Meeting Type	Annual
Ticker Symbol	PIRS	Meeting Date	30-Jun-2017
Record Date	08-May-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1STEPHEN S. YODER		For	For
	2MICHAEL RICHMAN		For	For
2.	RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For

PRA HEALTH SCIENCES, INC.

Security	69354M108	Meeting Type	Annual
Ticker Symbol	PRAH	Meeting Date	01-Jun-2017
Record Date	05-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1COLIN SHANNON		For	For
	2JAMES C. MOMTAZEE		For	For
2.	TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2017.	Management	For	For
3.	APPROVAL, IN A NON-BINDING ADVISORY VOTE, OF THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS.	Management	For	For
4.	RECOMMENDATION, IN A NON-BINDING, ADVISORY VOTE, OF WHETHER A NON-BINDING STOCKHOLDER VOTE TO APPROVE THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS SHOULD OCCUR EVERY ONE, TWO OR THREE YEARS.	Management	1 Year	For
5.	APPROVAL OF THE PRA HEALTH SCIENCES, INC. 2017 EMPLOYEE STOCK PURCHASE PLAN.	Management	For	For

RA PHARMACEUTICALS, INC.

Security	74933V108	Meeting Type	Annual
Ticker Symbol	RARX	Meeting Date	20-Jun-2017
Record Date	25-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1DOUGLAS A. TRECO, PH.D.		For	For
	2EDWARD T. MATHERS		For	For
2.	TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For

REGENERON PHARMACEUTICALS, INC.

Security	75886F107	Meeting Type	Annual
Ticker Symbol	REGN	Meeting Date	09-Jun-2017
Record Date	13-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.1	ELECTION OF DIRECTOR: BONNIE L. BASSLER	Management	For	For
1.2	ELECTION OF DIRECTOR: N. ANTHONY COLES	Management	For	For
1.3	ELECTION OF DIRECTOR: JOSEPH L. GOLDSTEIN	Management	For	For
1.4	ELECTION OF DIRECTOR: CHRISTINE A. POON	Management	For	For
1.5	ELECTION OF DIRECTOR: P. ROY VAGELOS	Management	For	For
1.6	ELECTION OF DIRECTOR: HUDA Y. ZOGHBI	Management	For	For
2	RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For
3	PROPOSAL TO APPROVE THE AMENDED AND RESTATED REGENERON PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLAN	Management	For	For
4	PROPOSAL TO APPROVE, ON AN ADVISORY BASIS, EXECUTIVE COMPENSATION.	Management	For	For
5	PROPOSAL TO APPROVE, ON AN ADVISORY BASIS, THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION.	Management	3 Years	For

SAGE THERAPEUTICS, INC.

Security	78667J108	Meeting Type	Annual
Ticker Symbol	SAGE	Meeting Date	07-Jun-2017
Record Date	10-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: MICHAEL COLA	Management	For	For
1B.	ELECTION OF DIRECTOR: JEFFREY M. JONAS	Management	For	For
2.	TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For
3.	APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS.	Management	For	For

SAREPTA THERAPEUTICS INC.

Security	803607100	Meeting Type	Annual
Ticker Symbol	SRPT	Meeting Date	06-Jun-2017
Record Date	11-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.1	ELECTION OF GROUP II DIRECTOR: RICHARD J. BARRY	Management	For	For
1.2	ELECTION OF GROUP II DIRECTOR: M. KATHLEEN BEHRENS, PH.D.	Management	For	For
1.3	ELECTION OF GROUP II DIRECTOR: CLAUDE NICAISE, M.D.	Management	For	For
2.	ADVISORY VOTE TO APPROVE, ON A NON-BINDING BASIS, NAMED EXECUTIVE OFFICER COMPENSATION	Management	For	For
3.	ADVISORY VOTE ON WHETHER AN ADVISORY VOTE ON EXECUTIVE COMPENSATION SHOULD BE HELD EVERY ONE, TWO OR THREE YEARS	Management	1 Year	For
4.	RATIFICATION OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2017	Management	For	For

SHIRE PLC

Security	82481R106	Meeting Type	Annual
Ticker Symbol	SHPG	Meeting Date	25-Apr-2017
Record Date	23-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	TO RECEIVE THE COMPANY’S ANNUAL REPORT AND ACCOUNTS FOR THE YEAR ENDED DECEMBER 31, 2016.	Management	For	For
2.	TO APPROVE THE DIRECTORS’ REMUNERATION REPORT, EXCLUDING THE DIRECTORS’ REMUNERATION POLICY, SET OUT ON PAGES 82 TO 114 OF THE ANNUAL REPORT AND ACCOUNTS FORTHE YEAR ENDED DECEMBER 31, 2016.	Management	For	For
3.	TO RE-ELECT DOMINIC BLAKEMORE AS A DIRECTOR.	Management	For	For
4.	TO RE-ELECT OLIVIER BOHUON AS A DIRECTOR.	Management	For	For
5.	TO RE-ELECT WILLIAM BURNS AS A DIRECTOR.	Management	For	For
6.	TO ELECT IAN CLARK AS A DIRECTOR.	Management	For	For
7.	TO ELECT GAIL FOSLER AS A DIRECTOR.	Management	For	For
8.	TO RE-ELECT DR. STEVEN GILLIS AS A DIRECTOR.	Management	For	For
9.	TO RE-ELECT DR. DAVID GINSBURG AS A DIRECTOR.	Management	For	For
10.	TO RE-ELECT SUSAN KILSBY AS A DIRECTOR.	Management	For	For
11.	TO RE-ELECT SARA MATHEW AS A DIRECTOR.	Management	For	For
12.	TO RE-ELECT ANNE MINTO AS A DIRECTOR.	Management	For	For
13.	TO RE-ELECT DR. FLEMMING ORNSKOV AS A DIRECTOR.	Management	For	For
14.	TO RE-ELECT JEFFREY POULTON AS A DIRECTOR.	Management	For	For
15.	TO ELECT ALBERT STROUCKEN AS A DIRECTOR.	Management	For	For
16.	TO RE-APPOINT DELOITTE LLP AS THE COMPANY’S AUDITOR UNTIL THE CONCLUSION OF THE NEXT ANNUAL GENERAL MEETING OF THE COMPANY.	Management	For	For
17.	TO AUTHORIZE THE AUDIT, COMPLIANCE & RISK COMMITTEE TO DETERMINE THE REMUNERATION OF THE AUDITOR.	Management	For	For
18.	THAT THE AUTHORITY TO ALLOT RELEVANT SECURITIES (AS DEFINED IN THE COMPANY’S ARTICLES OF ASSOCIATION (THE “ARTICLES”)) CONFERRED ON THE DIRECTORS BY ARTICLE 10 PARAGRAPH (B) OF THE ARTICLES BE RENEWED AND FOR THIS PURPOSE THE AUTHORISED ALLOTMENT AMOUNT SHALL BE: (A)  15,104,181.75 OF RELEVANT SECURITIES AND (B) SOLELY IN CONNECTION WITH AN ALLOTMENT PURSUANT TO AN OFFER BY WAY OF A RIGHTS ISSUE (AS DEFINED IN THE ARTICLES, BUT ONLY IF AND TO THE EXTENT THAT SUCH OFFER IS ... (DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL)	Management	For	For
19.	THAT, SUBJECT TO THE PASSING OF RESOLUTION 18, THE AUTHORITY TO ALLOT EQUITY SECURITIES (AS DEFINED IN THE COMPANY’S ARTICLES OF ASSOCIATION (THE “ARTICLES”)) WHOLLY FOR CASH CONFERRED ON THE DIRECTORS BY ARTICLE 10 PARAGRAPH (D) OF THE ARTICLES BE RENEWED AND FOR THIS PURPOSE THE NON PRE-EMPTIVE AMOUNT (AS DEFINED IN THE ARTICLES) SHALL BE 2,265,627.25 AND THE ALLOTMENT PERIOD SHALL BE THE PERIOD COMMENCING ON APRIL 25, 2017, AND ENDING ON THE EARLIER OF THE CLOSE OF ... (DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL)	Management	For	For
20.	THAT, SUBJECT TO THE PASSING OF RESOLUTIONS 18 AND 19 AND FOR THE PURPOSE OF THE AUTHORITY TO ALLOT EQUITY SECURITIES (AS DEFINED IN THE COMPANY’S ARTICLES OF ASSOCIATION (THE “ARTICLES”)) WHOLLY FOR CASH CONFERRED ON THE DIRECTORS BY ARTICLE 10 PARAGRAPH (D) OF THE ARTICLES AND RENEWED BY RESOLUTION 19, THE NON PRE- EMPTIVE AMOUNT (AS DEFINED IN THE ARTICLES) SHALL BE INCREASED FROM 2,265,627.25 TO 4,531,254.50 AND THE ALLOTMENT PERIOD SHALL BE THE PERIOD COMMENCING ON ... (DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL)	Management	For	For
21.	THAT THE COMPANY BE AND IS HEREBY GENERALLY AND UNCONDITIONALLY AUTHORIZED: (A) PURSUANT TO ARTICLE 57 OF THE COMPANIES (JERSEY) LAW 1991 TO MAKE MARKET PURCHASES OF ORDINARY SHARES IN THE CAPITAL OF THE COMPANY, PROVIDED THAT: (1) THE MAXIMUM NUMBER OF ORDINARY SHARES HEREBY AUTHORIZED TO BE PURCHASED IS 90,625,090, (2) THE MINIMUM PRICE, EXCLUSIVE OF ANY EXPENSES, WHICH MAY BE PAID FOR AN ORDINARY SHARE IS FIVE PENCE, (3) THE MAXIMUM PRICE, EXCLUSIVE OF ANY EXPENSES, WHICH MAY BE PAID ... (DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL)	Management	For	For
22.	THAT, WITH EFFECT FROM THE CONCLUSION OF THE ANNUAL GENERAL MEETING, THE COMPANY’S ARTICLES OF ASSOCIATION BE AMENDED AND THOSE ARTICLES PRODUCED TO THE MEETING AND INITIALED BY THE CHAIRMAN BE ADOPTED AS THE COMPANY’S ARTICLES OF ASSOCIATION, IN SUBSTITUTION FOR, AND TO THE EXCLUSION OF, THE EXISTING ARTICLES OF ASSOCIATION OF THE COMPANY.	Management	For	For
23.	TO APPROVE THAT A GENERAL MEETING OF THE COMPANY, OTHER THAN AN ANNUAL GENERAL MEETING, MAY BE CALLED ON NOT LESS THAN 14 CLEAR DAYS’ NOTICE.	Management	For	For

TETRAPHASE PHARMACEUTICALS, INC.

Security	88165N105	Meeting Type	Annual
Ticker Symbol	TTPH	Meeting Date	31-May-2017
Record Date	05-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1L PATRICK GAGE		For	For
	2NANCY WYSENSKI		For	For
2.	TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For
3.	TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.	Management	For	For

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Security	881624209	Meeting Type	Annual
Ticker Symbol	TEVA	Meeting Date	13-Jul-2017
Record Date	13-Jun-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR TO SERVE UNTIL 2020 ANNUAL MEETING: DR. SOL J. BARER	Management	For	For
1B.	ELECTION OF DIRECTOR TO SERVE UNTIL 2020 ANNUAL MEETING: MR. JEAN-MICHEL HALFON	Management	For	For
1C.	ELECTION OF DIRECTOR TO SERVE UNTIL 2020 ANNUAL MEETING: MR. MURRAY A. GOLDBERG	Management	For	For
1D.	ELECTION OF DIRECTOR TO SERVE UNTIL 2020 ANNUAL MEETING: MR. NECHEMIA (CHEMI) J. PERES	Management	For	For
1E.	ELECTION OF DIRECTOR TO SERVE UNTIL 2019 ANNUAL MEETING: MR. ROBERTO MIGNONE	Management	For	For
1F.	ELECTION OF DIRECTOR TO SERVE UNTIL 2019 ANNUAL MEETING: DR. PERRY D. NISEN	Management	For	For
2.	TO APPROVE THE COMPENSATION OF DR. SOL J. BARER AS CHAIRMAN OF THE BOARD OF DIRECTORS.	Management	For	For
3.	TO APPROVE THE TERMS OF OFFICE AND EMPLOYMENT OF DR. YITZHAK PETERBURG ASINTERIM PRESIDENT AND CHIEF EXECUTIVE OFFICER.	Management	For	For
4.	TO APPROVE A MEMBERSHIP FEE FOR DIRECTORS SERVING ON SPECIAL OR AD-HOC COMMITTEES.	Management	For	For
5.	TO APPROVE AN AMENDMENT TO THE 2015 LONG-TERM EQUITY-BASED INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES AVAILABLE FOR ISSUANCE THEREUNDER.	Management	For	For
6.	TO APPROVE TEVA’S 2017 EXECUTIVE INCENTIVE COMPENSATION PLAN.	Management	For	For
7.	TO REDUCE TEVA’S REGISTERED SHARE CAPITAL TO NIS 249,434,338, ...(DUE TO SPACE LIMITS, SEE PROXY MATERIAL FOR FULL PROPOSAL).	Management	For	For
8.	TO APPOINT KESSELMAN & KESSELMAN, A MEMBER OF PRICEWATERHOUSECOOPERS INTERNATIONAL LTD., AS TEVA’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM UNTIL THE 2018 ANNUAL MEETING OF SHAREHOLDERS.	Management	For	For

THERMO FISHER SCIENTIFIC INC.

Security	883556102	Meeting Type	Annual
Ticker Symbol	TMO	Meeting Date	17-May-2017
Record Date	27-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: MARC N. CASPER	Management	For	For
1B.	ELECTION OF DIRECTOR: NELSON J. CHAI	Management	For	For
1C.	ELECTION OF DIRECTOR: C. MARTIN HARRIS	Management	For	For
1D.	ELECTION OF DIRECTOR: TYLER JACKS	Management	For	For
1E.	ELECTION OF DIRECTOR: JUDY C. LEWENT	Management	For	For
1F.	ELECTION OF DIRECTOR: THOMAS J. LYNCH	Management	For	For
1G.	ELECTION OF DIRECTOR: JIM P. MANZI	Management	For	For
1H.	ELECTION OF DIRECTOR: WILLIAM G. PARRETT	Management	For	For
1I.	ELECTION OF DIRECTOR: LARS R. SORENSEN	Management	For	For
1J.	ELECTION OF DIRECTOR: SCOTT M. SPERLING	Management	For	For
1K.	ELECTION OF DIRECTOR: ELAINE S. ULLIAN	Management	For	For
1L.	ELECTION OF DIRECTOR: DION J. WEISLER	Management	For	For
2.	AN ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.	Management	For	For
3.	AN ADVISORY VOTE ON THE FREQUENCY OF FUTURE EXECUTIVE COMPENSATION ADVISORY VOTES.	Management	1 Year	For
4.	RATIFICATION OF THE AUDIT COMMITTEE’S SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT AUDITORS FOR 2017.	Management	For	For

ULTRAGENYX PHARMACEUTICAL INC.

Security	90400D108	Meeting Type	Annual
Ticker Symbol	RARE	Meeting Date	22-Jun-2017
Record Date	24-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1A.	ELECTION OF DIRECTOR: EMIL D. KAKKIS, M.D., PH.D.	Management	For	For
1B.	ELECTION OF DIRECTOR: DANIEL G. WELCH	Management	For	For
2.	RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For
3.	ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.	Management	For	For

UNIVERSAL HEALTH SERVICES, INC.

Security	913903100	Meeting Type	Annual
Ticker Symbol	UHS	Meeting Date	17-May-2017
Record Date	21-Mar-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1LAWRENCE S. GIBBS		For	For
2.	THE APPROVAL OF AMENDMENT TO THE UNIVERSAL HEALTH SERVICES, INC. THIRD AMENDED AND RESTATED 2005 STOCK INCENTIVE PLAN.	Management	For	For
3.	ADVISORY (NONBINDING) VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.	Management	For	For
4.	ADVISORY (NONBINDING) VOTE ON THE FREQUENCY OF AN ADVISORY STOCKHOLDER VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION.	Management	3 Years	For
5.	PROPOSAL TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2017.	Management	For	For
6.	STOCKHOLDER PROPOSAL REGARDING PROXY ACCESS IF PROPERLY PRESENTED AT THE MEETING.	Shareholder	Against	For

VENITI, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	24-Aug-2016
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	SERIES D PREFERRED STOCK FINANCING	Management	For	For
2.	AUTHORIZATION OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION	Management	For	For
3.	WAIVER OF PREEMPTIVE RIGHTS AND NOTICE	Management	For	For
4.	ADOPTION OF THE MERGER DOCUMENTS	Management	For	For
5.	ADOPTION OF FORMS OF STOCK OPTION AGREEMENT	Management	For	For
6.	WAIVER OF APPRAISAL AND DISSENTERS’ RIGHTS	Management	For	For
7.	WAIVER OF NOTICE	Management	For	For
8.	TERMINATION OF CERTAIN AGREEMENTS	Management	For	For
9.	APPOINTMENT OF STOCKHODLER REPRESENTATIVE COMMITTEE	Management	For	For
10.	OMNIBUS RESOLUTIONS	Management	For	For

VENITI, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	25-Apr-2017
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	INCREASE IN 2010 EQUITY INCENTIVE PLAN	Management	For	For

VERTEX PHARMACEUTICALS INCORPORATED

Security	92532F100	Meeting Type	Annual
Ticker Symbol	VRTX	Meeting Date	08-Jun-2017
Record Date	12-Apr-2017

Item	Proposal	Proposed by	Vote	For/Against Mgmt
1.	DIRECTOR	Management
	1ALAN GARBER		For	For
	2MARGARET G. MCGLYNN		For	For
	3WILLIAM D. YOUNG		For	For
2.	AMENDMENTS TO OUR CHARTER AND BY-LAWS TO PROVIDE FOR THE DECLASSIFICATION OF OUR BOARD OF DIRECTORS.	Management	For	For
3.	AMENDMENT AND RESTATEMENT OF OUR 2013 STOCK AND OPTION PLAN, TO AMONG OTHER THINGS, INCREASE THE NUMBER OF SHARES AVAILABLE UNDER THE PLAN BY 6.75 MILLION SHARES.	Management	For	For
4.	RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2017.	Management	For	For
5.	ADVISORY VOTE ON OUR NAMED EXECUTIVE OFFICER COMPENSATION.	Management	For	For
6.	ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON EXECUTIVE COMPENSATION PROGRAM.	Management	1 Year	For
7.	SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT WE TAKE STEPS NECESSARY TO ELIMINATE SUPERMAJORITY PROVISIONS FROM OUR CHARTER AND BY-LAWS.	Shareholder	Against	For
8.	SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT WE PREPARE A REPORT ON OUR POLICIES AND ACTIVITIES WITH RESPECT TO LOBBYING.	Shareholder	Against	For

SIGNATURES

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant)	Tekla Healthcare Investors
By (Signature and Title)*
	/s/ Daniel R. Omstead
	(Daniel R. Omstead, President)
Date	8/30/17

*Print the name and title of each signing officer under his or her signature.

2